RNA & Oligonucleotide Therapeutics        
March 29 - April 1, 2017
Abstract Deadline: January 31, 2017


Annemieke Aartsma-Rus, Leiden University Medical Center, Netherlands
Matthew Levy, Albert Einstein College of Medicine
Melissa Moore,
Moderna Therapeutics
Laura Sepp-Lorenzino, Alnylam Pharmaceuticals Inc.

We are pleased to announce the fifth Cold Spring Harbor conference on RNA and Oligonucleotide Therapeutics, which will begin at 7:30 pm on Wednesday, March 29th and run through lunch on Saturday, April 1, 2017.

  • mRNA therapeutics (Chairs Melissa Moore & Mariola Fotin-Mleczek)
  • Single stranded oligonucleotides (Chairs Annemieke Aartsma-Rus & Adrian Krainer)
  • Double stranded oligonucleotides (Chairs Laura Sepp-Lorenzino & David Lewis)
  • Preclinical considerations (Chairs Art Levin and Laura Sepp-Lorenzino)
  • Aptamers (Chairs Matthew Levy & tba)
Keynote Speaker:

Anastasia Khvorova, University of Massachusetts Medical School 

Invited Speakers:
Annemieke Aartsma-Rus, Leiden University Medical Center, Netherlands
Bob Brown, Dicerna
Chris Brown, Alnylan Pharmaceuticals
Donald Burke, University of Missouri
Erik Bush, Arrowhead
Pad Chivukula, Arcturus Therapeutics
Adrian Dana, Alnylam Pharmaceuticals
Mariola Fotin-Mleczek, CureVac, Germany
Nagy Habib, MiNA Therapeutics
Michelle Hastings, Rosalind Franklin University
Maja Janas, Alnylam Pharmaceuticals
Nebojsa Janjic, SOMAlogic
Katalin Karikó, BioN Tech RNA Pharmaceuticals, Germany
Alem Kahsai, Duke University
Jae Kim, Alnylam Pharmaceuticals
Adrian Krainer, Cold Spring Harbor Laboratory
Arthur Krieg, Checkmate Pharmaceuticals
Pete Leone, Arrowhead
Tom McCauley, RaNA Therapeutics
Brett Monia, Ionis Pharmaceuticals
Norbert Pardi, University of Pennsylvania
Marco Passini, Sarepta Therapeutics
Justin Richner, Washington University in St. Louis
Bruce Sullenger, Duke University

Abstracts are welcomed on all scientific topics related to the development of RNA and other oligonucleotide-based therapeutic approaches. They should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. The status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We are eager to have as many young people as possible to attend since they are likely to benefit most from this meeting. We have applied for funds from industry to partially support graduate students and postdocs. Please apply in writing via email to Maureen Morrow and state your financial needs. Preference will be given to those submitting abstracts.

Social Media
The designated hashtag for this meeting is #cshlRNATX. Note that you must obtain permission from an individual presenter before live-tweeting or discussing his/her talk, poster, or research results on social media. Click the Policies tab above to see our full Confidentiality & Reporting Policy.

We look forward to seeing you at Cold Spring Harbor in March.

Support for this meeting generously provided by:
Major Sponsors   Moderna Therapeutics and RaNA Therapeutics
Sponsor   Alnylam Pharmaceuticals
Partner Arcturus Therapeutics

Academic Package $1165
Graduate/PhD Student Package $975
Corporate Package $1475
Academic/Student No-Housing Package $795
Corporate No-Housing Package $995

Regular packages are all-inclusive and cover registration, food, housing, parking, a wine-and-cheese party, cocktail reception, and lobster banquet. No-Housing packages include all costs except housing. Full payment is due four weeks prior to the meeting.